Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-06-06
1998-07-21
Jacobson, Dian C.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4351723, 4353201, 435193, 536 231, C07K 1481, C07K 14815, C12N 1515
Patent
active
057834210
ABSTRACT:
A novel polypeptide derived from the leech Hirudo medicinalis was found to be able to inhibit Factor Xa thereby reducing the extent of blood coagulation. The polypeptide is useful in treating conditions of excessive blood coagulation. A recombinant organism containing cDNA encoding the polypeptide has been deposited in the ATCC under Accession No. 69134. Recombinant microorganisms able to produce the polypeptide have been deposited in the ATCC under Accession Nos. 69135, 69137 and 69269.
REFERENCES:
patent: 4588587 (1986-05-01), Gasic
patent: 4742004 (1988-05-01), Hartman et al.
patent: 4791100 (1988-12-01), Kramer et al.
patent: 4832849 (1989-05-01), Cardin
patent: 5114922 (1992-05-01), Maschler
patent: 5182113 (1993-01-01), Rigbi et al.
patent: 5403596 (1995-04-01), Rigbi et al.
Baskova et al., Chemical Abstracts, 106:60996w (1986).
Condra et al., "Isolation and Structural Characterization of a Potent Inhibitor of Coagulation Factor Xa from the Leech Haementeria ghilianii", Thrombosis and Homeostasis 61(3):437-441 (1989).
Ferrailo, Bobbe L. and Mohler, Marjorie A., "Goals and Analytical Methodologies for Protein Disposition Studies", Protein Pharmacokinetics and Metabolism; Plenum Press. New York, (1992) pp. 1-33.
Han et al., (1989) "Cloning and Expression of cDNA Encoding Antistasin, a Leech-Derived Protein Having Anti-Coagulant and Anti-Metastatic Properties", Gene 75:47-57.
Gasic et al., Cancer Res. 43:1633-1636 (1983).
Gasic et al., Cancer Res. 44:5670-5676 (1984).
Gasic et al., Chemical Abstracts 110:185955w (1986).
Hoffman et al., (1992) "Site-Directed Mutagenesis of the Leech-Dervied Factor Xa Inhibitor Antistasin", Journ. Biol. Chem., 287:943-949.
Hopp etal., (1988) "A Short Polypeptide Marker Sequence Useful For Recombinant Protein Identification and Purification", Bio/technology 6:1204-1210.
Konrad, Michael W., (1993) "The Immune System as a Barrier to Delivery of Protein Therapeutics", Biological Barriers to Protein Delivery, Plenum Press, New York, pp. 409-437.
Nutt et al., (1988) "the Amino Acid Sequence of Antistasin", Journ. Biol. Chem. 263(21):10162-10164.
Rigbi et al., (1990) Chemical Abstracts, 113:46259w.
Tuszynski et al., (1987) "Isolation and Characterization of Antistasin", 262(20):9718-9723.
Dunwiddie et al., (1989), J. Biol. Chem. 264(28):16694-16699.
Sollner et al., Eur. J. Biochem. 219:937-943 (1994).
Levanon Avigdor
Werber Moshe M.
Zeelon Elisha P.
Bio-Technology General Corp.
Jacobson Dian C.
White John P.
LandOfFree
DNA encoding novel polypeptide having Factor Xa inhibitory activ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding novel polypeptide having Factor Xa inhibitory activ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding novel polypeptide having Factor Xa inhibitory activ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1646081